Identification of 153 new loci associated with heel bone mineral density and functional involvement of GPC6 in osteoporosis.
Kemp JP., Morris JA., Medina-Gomez C., Forgetta V., Warrington NM., Youlten SE., Zheng J., Gregson CL., Grundberg E., Trajanoska K., Logan JG., Pollard AS., Sparkes PC., Ghirardello EJ., Allen R., Leitch VD., Butterfield NC., Komla-Ebri D., Adoum A-T., Curry KF., White JK., Kussy F., Greenlaw KM., Xu C., Harvey NC., Cooper C., Adams DJ., Greenwood CMT., Maurano MT., Kaptoge S., Rivadeneira F., Tobias JH., Croucher PI., Ackert-Bicknell CL., Bassett JHD., Williams GR., Richards JB., Evans DM.
Osteoporosis is a common disease diagnosed primarily by measurement of bone mineral density (BMD). We undertook a genome-wide association study (GWAS) in 142,487 individuals from the UK Biobank to identify loci associated with BMD as estimated by quantitative ultrasound of the heel. We identified 307 conditionally independent single-nucleotide polymorphisms (SNPs) that attained genome-wide significance at 203 loci, explaining approximately 12% of the phenotypic variance. These included 153 previously unreported loci, and several rare variants with large effect sizes. To investigate the underlying mechanisms, we undertook (1) bioinformatic, functional genomic annotation and human osteoblast expression studies; (2) gene-function prediction; (3) skeletal phenotyping of 120 knockout mice with deletions of genes adjacent to lead independent SNPs; and (4) analysis of gene expression in mouse osteoblasts, osteocytes and osteoclasts. The results implicate GPC6 as a novel determinant of BMD, and also identify abnormal skeletal phenotypes in knockout mice associated with a further 100 prioritized genes.